Atrial Fibrillation, Paroxysmal or Persistent
6
2
3
1
Key Insights
Highlights
Success Rate
100% trial completion (above average)
Treatment Research
6 treatments under study, led by Deep Sedation
Research Leaders
8 sponsors active, led by Vivek Reddy
Related Conditions
Often studied with 13 related conditions
Clinical Risk Assessment
Based on trial outcomes
Moderate Risk
Score: 50/100
0.0%
0 terminated out of 6 trials
100.0%
+13.4% vs benchmark
0%
0 trials in Phase 3/4
0%
0 of 1 completed with results
Key Signals
Data Visualizations
Phase Distribution
Trial Status
Trial Success Rate
Benchmark: 86.6%
Based on 1 completed trials
Clinical Trials (6)
Reversal of Atrial Substrate to Prevent Atrial Fibrillation Cohort Study
Safety and Efficacy of the CoolCryo System for Cardiac Cryoablation in the Treatment of Atrial Fibrillation
Versatility of a Circular Multielectrode Catheter in the Individualized Recognition & Treatment of Atrial Fibrillation and Related Arrhythmias Using Pulsed Field Energy
RESOLVE-AF: Clinical Evaluation of the Ablacath™ Mapping Catheter and Ablamap® System Utilizing Electrographic Flow (EGF) Mapping to Resolve Extra-PV Sources of Atrial Fibrillation and Guide Ablation Therapy.
Deep Sedation in Catheter Ablation of Atrial Fibrillation
The SAFE Prospective Registry
Research Network
Common Treatments
- Deep Sedation1
- Electrographic Flow Egf Mapping No Ablation1
- Varipulse Catheter Ablation1
- Catheter Ablation Andor Electrical Cardioversion1
- Electrographic Flow Egf Mapping And Ablation Of Egfidentified Sources Of Atrial Fibrillation1
Active Sponsors
- Vivek Reddy1
- University Hospital Ostrava1
- Medinice S.A.1
- Ablacon, Inc.1
- Cortex1
Top Investigators
Piedmont Athens Regional
The First Affiliated Hospital of Dalian Medical University
St. Antonius Hospital
Nova Scotia Health
Icahn School of Medicine at Mount Sinai
Related Conditions
- Atrial Fibrillation2
- Atrial Flutter1
- Atrial Fibrillation Paroxysmal1
- Mitral Valve Disease1
- Atrial Arrhythmia1